- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2012 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
PHARMACEUTICALS
6:00pm
Dec 5, 2012
UK to lead stem cell research project
£45m European project to generate cells for research
PHARMACEUTICALS
Dec 5, 2012
Drugs groups aim to halve cost of trials
Move comes as sales of new medicines slows
- Cost of developing drugs jumps tenfold
- Undercover Economist Unloading the dice on research
HEALTH CARE
Dec 4, 2012
Baxter in $4bn deal for Sweden’s Gambro
US healthcare group boosts presence in dialysis market
PHARMACEUTICALS
Dec 4, 2012
Patent expiries trigger pain drugs battle
Generic drug companies want to sell copies of narcotic painkillers
- Intellectual property Patent lore
- Novartis offsets effects of patent expiry
PHARMACEUTICALS
Dec 2, 2012
Cost of developing drugs jumps tenfold
Study stresses regulatory hurdles and return on capital demands
Dec 2, 2012
Allergan obesity business attracts buyers
The company produces Lap Band gastric devices, which constrict the stomach to reduce appetite
From
INDUSTRIALS
Dec 2, 2012
Tax threat prompts US dealmaking flurry
Companies rush to close deals as fiscal cliff deadline looms
- First Quantum hurt by Inmet’s rejection
- Number Cruncher Britvic’s bitter aftertaste
HEALTH CARE
Dec 1, 2012
Castlebeck set to be taken over
Private equity-backed Partnerships in Care among potential buyers
From
INDUSTRIALS
Dec 1, 2012
SThree to consolidate existing locations
White-collar recruiter is to slow its expansion into emerging markets
PHARMACEUTICALS
Nov 30, 2012
Teva restructuring beckons
Sales and earnings guidance below market expectations
The Top Line
from
MEDIA
Nov 30, 2012
‘Tis the season to be wary as gifts roll in
Great deal of evidence that gifts induce co-operation
From
LEX
Nov 30, 2012
Letter from Lex – perfect pairs
A week when the news arrives in twos, except for the banks
From
SPECIAL REPORTS
Nov 29, 2012
Biggest obstacle is human behaviour
In the fight against Aids, scientific advances and unprecedented funding run up against political sensitivities and rising complacency, writes Andrew Jack
From
WORLD
Nov 29, 2012
Warnings on PFI scheme went unheeded
Hospital overspent by fifth of its income
Nov 28, 2012
Nestlé health unit seeks Chinese remedy
Group in joint venture with traditional medicine company
HEALTH CARE
Nov 28, 2012
S&N buys US wound care group for $780m
Hip and joint maker expands into growing bioactives market
From
LEX
Nov 28, 2012
Smith & Nephew – non-invasive
UK medical devices group’s acquisition addresses key weakness
PHARMACEUTICALS
Nov 28, 2012
Outsourced drug trials lack oversight, study says
Analysis highlights gaps in the system of testing
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
IN DEPTH
MOST POPULAR IN COMPANIES
-
Strategic Supply Chain Manager - Major Bids
Engineering
-
Head of Information Security
Commerzbank
-
Project Director
FMCG / IT
-
Group Sales Director
Media
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Baxter / Gambro – no adrenalin rush
The deal is a reflection of the new normal that large corporations and even equity investors face